Saturday, November 19, 2011
Print Current Session:
|
|
Saturday
SESSION 43:
LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
Moderators:Brian R. Hopkinson, ChM, FRCS / Richard P. Cambria, MD
|
|
SESSION 43 SCHEDULE | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
12:00 PM - 12:05 PM | Latest Generation AAA Stent-Grafts Are Being Heralded As Important Advances: Are We Too Quick To Embrace Unproven Technology |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
12:06 PM - 12:11 PM | The Cordis INCRAFT AAA Endograft: A Lower Profile Device: Advantages And Disadvantages |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
12:12 PM - 12:17 PM | Experience With The TriVascular OVATION AAA Endograft: Results Of The Pivotal U.S. And Out Of U.S. Trials With A Unique Lower Profile Device |
Presenter(s):Francisco Valdes, MD / Michael D. Dake, MD | |
12:18 PM - 12:23 PM | Advantages And Benefits Of The New C3 Gore Excluder AAA Graft - Does The Ability To Reposition Make A Difference: The European And U.S. Experience |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Mark F. Fillinger, MD | |
12:24 PM - 12:29 PM | Clinical Experience With The Endologix (VENTANA) Off-The-Shelf Fenestrated Device For Juxtarenal AAAs: Advantages And Limitations |
Presenter(s):Daniel G. Clair, MD | |
12:30 PM - 12:35 PM | World And U.S. Experience With The Nellix Device For EVAR: A New Concept With Polymer Filled Bags Obliterating The AAA Sac And Maintaining Flow With Stents: Advantages, Limitations And Midterm Results |
Presenter(s):Clifford J. Buckley, MD / Andrew Holden, MBChB / Carlos E. Donayre, MD | |
12:36 PM - 12:41 PM | ANACONDA Fenestrated Endograft For Juxtarenal AAAs: Principles And Clinical Experience |
Presenter(s):Peter M. Bungay, MBChB | |
12:42 PM - 12:47 PM | U.S. Pivotal Trial Results With The ANACONDA Device For EVAR: Advantages And Limitations |
Presenter(s):Christopher J. Kwolek, MD | |
12:48 PM - 12:53 PM | U.S. Pivotal Trial And Other Experience With The AORFIX Device: Advantages And Limitations |
Presenter(s):Mark F. Fillinger, MD | |
12:54 PM - 1:00 PM | Panel Discussion |
END OF SESSION 43 | |
previous | next |